147 related articles for article (PubMed ID: 32695671)
1. A Novel Prediction Tool Based on Large Cohorts to Determine the Cancer-Specific Survival Probability of Patients With Locally Advanced Pancreatic Cancer After Irreversible Electroporation Treatment.
He C; Huang X; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():952. PubMed ID: 32695671
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer.
He C; Huang X; Zhang Y; Cai Z; Lin X; Li S
Front Oncol; 2020; 10():6. PubMed ID: 32038984
[TBL] [Abstract][Full Text] [Related]
3. Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery.
He C; Zhang Y; Cai Z; Lin X
BMC Cancer; 2019 Feb; 19(1):178. PubMed ID: 30813928
[TBL] [Abstract][Full Text] [Related]
4. Nomogram to Predict Cancer-Specific Survival in Patients with Pancreatic Acinar Cell Carcinoma: A Competing Risk Analysis.
He C; Zhang Y; Cai Z; Duan F; Lin X; Li S
J Cancer; 2018; 9(22):4117-4127. PubMed ID: 30519311
[No Abstract] [Full Text] [Related]
5. Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment.
He C; Sun S; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():590. PubMed ID: 32426278
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Model to Predict Cancer-Specific Survival for Patients With Gallbladder Carcinoma After Surgery: A Population-Based Analysis.
He C; Cai Z; Zhang Y; Lin X
Front Oncol; 2019; 9():1329. PubMed ID: 31921622
[TBL] [Abstract][Full Text] [Related]
7. Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis.
He C; Zhang Y; Cai Z; Lin X; Li S
J Cancer; 2018; 9(17):3156-3167. PubMed ID: 30210639
[No Abstract] [Full Text] [Related]
8. Identification of Circulating Biomarkers and Construction of a Prognostic Signature for Survival Prediction in Locally Advanced Pancreatic Cancer After Irreversible Electroporation.
He C; Sun S; Zhang Y; Li S
J Inflamm Res; 2021; 14():1689-1699. PubMed ID: 33953596
[TBL] [Abstract][Full Text] [Related]
9. The impact of surgery in metastatic pancreatic neuroendocrine tumors: a competing risk analysis.
He CB; Zhang Y; Cai ZY; Lin XJ
Endocr Connect; 2019 Mar; 8(3):239-251. PubMed ID: 30726772
[TBL] [Abstract][Full Text] [Related]
10. Score for the Survival Probability of Patients With Orbital Rhabdomyosarcoma After Surgery: A Long-Term and Large Cohort Study.
Zhang Y; He C; Lian Y; Xiao H
Front Oncol; 2020; 10():1590. PubMed ID: 32974196
[TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
[TBL] [Abstract][Full Text] [Related]
12. Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer.
He C; Sun S; Zhang Y; Li S
J Inflamm Res; 2021; 14():4795-4807. PubMed ID: 34584438
[TBL] [Abstract][Full Text] [Related]
13. Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer.
He C; Sun S; Huang X; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():622318. PubMed ID: 33604301
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer.
He C; Wang J; Sun S; Zhang Y; Li S
J Oncol; 2019; 2019():9346017. PubMed ID: 31214261
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer].
He CB; Wang J; Mao YZ; Lao XM; Li SP
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):948-954. PubMed ID: 36207984
[No Abstract] [Full Text] [Related]
16. Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study.
Xiao Z; Yan Y; Zhou Q; Liu H; Huang P; Zhou Q; Lai C; Zhang J; Wang J; Mao K
Cancer Manag Res; 2019; 11():2691-2708. PubMed ID: 31118768
[No Abstract] [Full Text] [Related]
17. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
[TBL] [Abstract][Full Text] [Related]
18. Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery.
Heger U; Mack C; Tjaden C; Pan F; Pausch T; Hinz U; Sommer CM; Hackert T
Pancreatology; 2021 Oct; 21(7):1349-1355. PubMed ID: 34404600
[TBL] [Abstract][Full Text] [Related]
19. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
[No Abstract] [Full Text] [Related]
20. Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival.
Woeste MR; Wilson KD; Kruse EJ; Weiss MJ; Christein JD; White RR; Martin RCG
Front Oncol; 2021; 11():817220. PubMed ID: 35096621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
